Skip to main content
Clinical Trials/ACTRN12620000321943
ACTRN12620000321943
Not yet recruiting
Phase 3

A double blind, randomised controlled pilot study of the effect of bisphosphonates versus placebo on parameters associated with fracture risk in patients on dialysis.

Westmead Hospital Research and Education Network0 sites114 target enrollmentMarch 9, 2020

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
End Stage Kidney Disease
Sponsor
Westmead Hospital Research and Education Network
Enrollment
114
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 9, 2020
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Westmead Hospital Research and Education Network

Eligibility Criteria

Inclusion Criteria

  • age 50 and over
  • Satellite haemodialysis

Exclusion Criteria

  • Planned parathyroid surgery
  • Planned living related kidney transplant surgery within 12 months
  • Active non skin malignancy
  • Bilateral hip replacement making DXA hip bone mineral density impossible and hip structural analysis impossible
  • Gastro oesophageal reflux or gastritis or peptic ulcer disease symptoms that are not controlled with regular medications
  • A serum parathyroid hormone (PTH) level less than 2 times the upper normal range of the intact\-PTH assay
  • A serum alkaline phosphatase (ALP) level below the normal lower range
  • Inability to provide informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials